Teleflex Incorporated (TFX) is a publicly traded Healthcare sector company. As of May 20, 2026, TFX trades at $135.19 with a market cap of $5.77B and a P/E ratio of -5.91. TFX moved +1.90% today. Year to date, TFX is +8.61%; over the trailing twelve months it is +6.56%. Its 52-week range spans $100.18 to $249.91. Analyst consensus is buy with an average price target of $145.38. Rallies surfaces TFX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Teleflex jumps after Q1 results beat expectations; 2026 outlook reiterated: Teleflex reported first-quarter 2026 results this morning (May 7, 2026), with adjusted EPS of $1.39 on revenue of $548.3 million, both above expectations. The company reiterated its full-year 2026 adjusted EPS outlook of $6.25 to $6.55, helping drive the stock higher.
| Metric | Value |
|---|---|
| Price | $135.19 |
| Market Cap | $5.77B |
| P/E Ratio | -5.91 |
| EPS | $-22.80 |
| Dividend Yield | 0.34% |
| 52-Week High | $249.91 |
| 52-Week Low | $100.18 |
| Volume | 561.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.13B |
| Net Income | $-1.01B |
| Gross Margin | 55.14% |
8 analysts cover TFX: 0 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.38.